- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Govt Seeks Tighter Oversight of Antimicrobials Through Draft Rule Change

New Delhi: The Ministry of Health and Family Welfare has proposed adding "antimicrobials" to the definition of a "new drug" under the New Drugs and Clinical Trials Rules, 2019.
If finalised, the change would require manufacturers to obtain permission from the Central Licensing Authority before applying to a State Licensing Authority for a manufacturing licence. The proposal was published in draft notification G.S.R. 983(E), dated November 6, 2026.
The draft proposes inserting the word “antimicrobials” after “monoclonal anti-body” in Rule 2(1)(w)(v), which lists products covered by the definition of a new drug. Under the rule’s explanation, products in this category are always deemed to be new drugs.
The draft stated:
"1. (i) These rules may be called the New Drugs and Clinical Trials (...... Amendment) Rules, 2025.(ii) These rules shall come into force from the date as specified by the Government at the time of final publication of the rules in the Official Gazette.2. In the New Drugs and Clinical Trials Rules, 2019, under the sub-rule (1)(w)(v) of rule 2, after the words “monoclonal anti-body,” the words “antimicrobials,” shall be inserted."
According to the Ministry, the proposal responds to concerns that manufacturing licences for antimicrobial products may be granted without adequate regulatory scrutiny, including assessments such as bioavailability, bioequivalence and stability studies. It said substandard or ineffective antimicrobials could contribute to antimicrobial resistance and pose risks to patients.
The proposed amendment seeks to bring antimicrobials within the regulatory framework applicable to new drugs under the New Drugs and Clinical Trials Rules, 2019. Accordingly, manufacturers would be required to obtain permission from the Central Licensing Authority (CLA) before applying for a manufacturing licence from the concerned State Licensing Authority (SLA). This is expected to strengthen central regulatory oversight and help ensure the quality, safety and efficacy of antimicrobial products.
The draft was published after consultation with the Drugs Technical Advisory Board under Sections 12(1) and 33(1) of the Drugs and Cosmetics Act, 1940. The Central Government has invited objections and suggestions within 30 days from the date copies of the Gazette containing the draft are made available to the public. Submissions may be sent to the Under Secretary (Drugs), Ministry of Health and Family Welfare, Kartavya Bhawan-1, New Delhi–110001, or emailed to drugsdiv-mohfw@gov.in. Press Information Bureau
The proposed change has not yet come into force. The draft says the commencement date will be specified when the final rules are published in the Official Gazette. Although the draft’s proposed rule title ends in “2025”, the notification itself is dated November 6, 2026.
To view the official notice, click the link below:
Mpharm (Pharmacology)
Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

